CN110818624B - Pyridine quaternary ammonium hydrazone compound, preparation method and application in antibacterial or slow release of spices - Google Patents
Pyridine quaternary ammonium hydrazone compound, preparation method and application in antibacterial or slow release of spices Download PDFInfo
- Publication number
- CN110818624B CN110818624B CN201911152808.0A CN201911152808A CN110818624B CN 110818624 B CN110818624 B CN 110818624B CN 201911152808 A CN201911152808 A CN 201911152808A CN 110818624 B CN110818624 B CN 110818624B
- Authority
- CN
- China
- Prior art keywords
- quaternary ammonium
- compound
- ammonium salt
- pyridine
- salt type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 Pyridine quaternary ammonium hydrazone compound Chemical class 0.000 title claims abstract description 97
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title claims abstract description 55
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims description 13
- 235000013599 spices Nutrition 0.000 title claims description 5
- 230000000844 anti-bacterial effect Effects 0.000 title abstract description 15
- 239000003205 fragrance Substances 0.000 claims abstract description 42
- 150000001875 compounds Chemical class 0.000 claims abstract description 39
- 150000002576 ketones Chemical class 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 239000002904 solvent Substances 0.000 claims description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 13
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 claims description 12
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical group O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 claims description 11
- 229940117916 cinnamic aldehyde Drugs 0.000 claims description 11
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 claims description 11
- GRFNBEZIAWKNCO-UHFFFAOYSA-N 3-pyridinol Chemical compound OC1=CC=CN=C1 GRFNBEZIAWKNCO-UHFFFAOYSA-N 0.000 claims description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 150000001299 aldehydes Chemical class 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 9
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 8
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- PBLNBZIONSLZBU-UHFFFAOYSA-N 1-bromododecane Chemical compound CCCCCCCCCCCCBr PBLNBZIONSLZBU-UHFFFAOYSA-N 0.000 claims description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 5
- 239000003513 alkali Substances 0.000 claims description 4
- 150000001350 alkyl halides Chemical class 0.000 claims description 4
- DXGPLGPVXNBIQZ-UHFFFAOYSA-L copper;2-hydroxybenzoate;methyl n-(1h-benzimidazol-2-yl)carbamate;6-methyl-n-phenyl-2,3-dihydro-1,4-oxathiine-5-carboxamide;quinolin-8-olate Chemical compound [Cu+2].OC1=CC=CC=C1C([O-])=O.C1=CN=C2C([O-])=CC=CC2=C1.C1=CC=C2NC(NC(=O)OC)=NC2=C1.S1CCOC(C)=C1C(=O)NC1=CC=CC=C1 DXGPLGPVXNBIQZ-UHFFFAOYSA-L 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000002304 perfume Substances 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- KOFZTCSTGIWCQG-UHFFFAOYSA-N 1-bromotetradecane Chemical compound CCCCCCCCCCCCCCBr KOFZTCSTGIWCQG-UHFFFAOYSA-N 0.000 claims description 3
- 240000007711 Peperomia pellucida Species 0.000 claims description 3
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical group CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 claims description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical group [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000002585 base Substances 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 15
- 230000007062 hydrolysis Effects 0.000 abstract description 11
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 11
- 239000007864 aqueous solution Substances 0.000 abstract description 9
- 230000003578 releasing effect Effects 0.000 abstract description 9
- 239000000243 solution Substances 0.000 abstract description 9
- 150000003934 aromatic aldehydes Chemical class 0.000 abstract description 8
- 230000002378 acidificating effect Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 239000004094 surface-active agent Substances 0.000 abstract description 3
- 239000000126 substance Substances 0.000 description 29
- 125000003118 aryl group Chemical group 0.000 description 13
- 239000001257 hydrogen Substances 0.000 description 13
- 229910052739 hydrogen Inorganic materials 0.000 description 13
- 150000002431 hydrogen Chemical class 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 238000010586 diagram Methods 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 239000000835 fiber Substances 0.000 description 5
- 238000002470 solid-phase micro-extraction Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000192125 Firmicutes Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- MYMSJFSOOQERIO-UHFFFAOYSA-N 1-bromodecane Chemical compound CCCCCCCCCCBr MYMSJFSOOQERIO-UHFFFAOYSA-N 0.000 description 2
- VMKOFRJSULQZRM-UHFFFAOYSA-N 1-bromooctane Chemical compound CCCCCCCCBr VMKOFRJSULQZRM-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000002262 Schiff base Substances 0.000 description 2
- 150000004753 Schiff bases Chemical class 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- PJDVXCKTCFPZQA-UHFFFAOYSA-N dodecane;hydrobromide Chemical compound Br.CCCCCCCCCCCC PJDVXCKTCFPZQA-UHFFFAOYSA-N 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- VPKMGDRERYMTJX-CMDGGOBGSA-N 1-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-1-penten-3-one Chemical compound CCC(=O)\C=C\C1C(C)=CCCC1(C)C VPKMGDRERYMTJX-CMDGGOBGSA-N 0.000 description 1
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
- LSXKDWGTSHCFPP-UHFFFAOYSA-N 1-bromoheptane Chemical compound CCCCCCCBr LSXKDWGTSHCFPP-UHFFFAOYSA-N 0.000 description 1
- HNTGIJLWHDPAFN-UHFFFAOYSA-N 1-bromohexadecane Chemical compound CCCCCCCCCCCCCCCCBr HNTGIJLWHDPAFN-UHFFFAOYSA-N 0.000 description 1
- MNDIARAMWBIKFW-UHFFFAOYSA-N 1-bromohexane Chemical compound CCCCCCBr MNDIARAMWBIKFW-UHFFFAOYSA-N 0.000 description 1
- AYMUQTNXKPEMLM-UHFFFAOYSA-N 1-bromononane Chemical compound CCCCCCCCCBr AYMUQTNXKPEMLM-UHFFFAOYSA-N 0.000 description 1
- YZWKKMVJZFACSU-UHFFFAOYSA-N 1-bromopentane Chemical compound CCCCCBr YZWKKMVJZFACSU-UHFFFAOYSA-N 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- LWBFNUKTNRHYKJ-UHFFFAOYSA-N Br.CCCCCCCCCCCCCCCC Chemical compound Br.CCCCCCCCCCCCCCCC LWBFNUKTNRHYKJ-UHFFFAOYSA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- HMKKIXGYKWDQSV-KAMYIIQDSA-N alpha-Amylcinnamaldehyde Chemical compound CCCCC\C(C=O)=C\C1=CC=CC=C1 HMKKIXGYKWDQSV-KAMYIIQDSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- POIARNZEYGURDG-FNORWQNLSA-N beta-damascenone Chemical compound C\C=C\C(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-FNORWQNLSA-N 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cis-cyclohexene Natural products C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000000596 cyclohexenyl group Chemical class C1(=CCCCC1)* 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- XZBIXDPGRMLSTC-UHFFFAOYSA-N formohydrazide Chemical compound NNC=O XZBIXDPGRMLSTC-UHFFFAOYSA-N 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229930002839 ionone Natural products 0.000 description 1
- 150000002499 ionone derivatives Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 229930007850 β-damascenone Natural products 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/50—Perfumes
- C11D3/502—Protected perfumes
- C11D3/507—Compounds releasing perfumes by thermal or chemical activation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- General Health & Medical Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pyridine Compounds (AREA)
Abstract
本发明公开了一种吡啶季铵盐型腙类化合物,具有以下所示结构:
式中各取代基定义详见说明书。本发明带有长碳链的吡啶季铵盐腙类化合物,具有良好的水溶性,可在酸性水溶液中水解释放芳香醛酮物质,通过动态平衡达到实现香料缓慢释放的目的。同时,水解之后留在溶液体系中的吡啶季铵盐型酰肼化合物依然具有良好的表面活性及抗菌能力,是一种多功能的表面活性剂,这在实际应用中具有一定的积极意义。The invention discloses a pyridine quaternary ammonium salt type hydrazone compound, which has the following structure:
For the definition of each substituent in the formula, see the description for details. The pyridine quaternary ammonium hydrazone compounds with long carbon chains in the invention have good water solubility, can be hydrolyzed in acidic aqueous solution to release aromatic aldehydes and ketones, and achieve the purpose of slowly releasing fragrances through dynamic balance. At the same time, the pyridine quaternary ammonium salt type hydrazide compound remaining in the solution system after hydrolysis still has good surface activity and antibacterial ability, and is a multifunctional surfactant, which has certain positive significance in practical applications.Description
技术领域technical field
本发明属于新型吡啶季铵盐腙类化合物的合成技术领域,具体的说,涉及一种吡啶季铵盐腙类化合物及制备方法与在抗菌或香料缓释中的应用。The invention belongs to the technical field of synthesis of novel pyridine quaternary ammonium hydrazone compounds, and in particular relates to a pyridine quaternary ammonium hydrazone compound, its preparation method and its application in antibacterial or perfume slow-release.
背景技术Background technique
随着社会不断发展,科技不断进步,人民的生活水平也在不断提高,在满足基本的物质生活需求后开始追求更高品质的生活。香精香料广泛存在于日常生活中,如食品添加剂、日化用品加香等,香精香料无处不在。近年来,芳香壁纸、芳香高档座椅、芳香纺织品的不断出现印证了人民群众对传统香料已经不再满足,人们渴望更加功能性、香味更持久的加香品。同时,香精的作用也不仅限于释放香气令人心情愉悦,同时还会起到许多诸如杀菌抗菌及疾病治疗的作用。香精具有如此广泛的使用价值,对它的研究也是一个极具经济价值与社会意义的课题。但由于香料分子本身具有饱和蒸气压比较高易挥发和易氧化不稳定的特点,致使其不能保持持久的留香时间。为了解决这个问题,近年来也提出了多种方法(综述:Quellet,C,Schudel,M,Ringgenberg,R.Chimia 2001;55:421-428),包括微胶囊包裹法(综述:Ciriminna,R,Pagliaro,M.Chem.Soc.Rev.2013;42:9243-9250;He L,Hu J,Deng W.Polym.Chem.2018,9:4926-4946)、有机金属框架材料吸附法(Liu Y,Wang Y,HuangJ,Zhou Z,Zhao D,Jiang L,Shen Y.AIChE J.2019;65:491-499)和化学潜香体法(Herrmann A.Angew.Chem.Int.Ed.2007;46:5836-5863)等等;其中,设计和制备高效的化学潜香体的研究受到广泛的关注和研究。With the continuous development of society and the continuous advancement of science and technology, people's living standards are also constantly improving. After meeting the basic material needs of life, they begin to pursue a higher quality of life. Flavors and fragrances widely exist in daily life, such as food additives, daily chemical products, etc., flavors and fragrances are everywhere. In recent years, the continuous emergence of aromatic wallpapers, aromatic high-end seats, and aromatic textiles has confirmed that the people are no longer satisfied with traditional spices, and people desire more functional and longer-lasting fragrance products. At the same time, the function of essence is not limited to releasing fragrance to make people feel happy, but also plays many functions such as sterilization, antibacterial and disease treatment. Fragrance has such a wide range of use values, and its research is also a topic of great economic value and social significance. However, because the fragrance molecule itself has the characteristics of relatively high saturated vapor pressure, volatile and easily oxidized instability, it cannot maintain a lasting fragrance retention time. In order to solve this problem, various methods have also been proposed in recent years (review: Quellet, C, Schudel, M, Ringgenberg, R. Chimia 2001; 55:421-428), including microencapsulation method (review: Ciriminna, R, Pagliaro, M.Chem.Soc.Rev.2013; 42:9243-9250; He L, Hu J, Deng W.Polym.Chem.2018,9:4926-4946), organometallic framework material adsorption method (Liu Y, Wang Y, HuangJ, Zhou Z, Zhao D, Jiang L, Shen Y.AIChE J.2019;65:491-499) and chemical latent fragrance method (Herrmann A.Angew.Chem.Int.Ed.2007;46: 5836-5863) and so on; among them, the design and preparation of efficient chemical latent aroma body research has received extensive attention and research.
香气缓释目前有多种方法,采用潜香体延缓香料释放的方法即用化学手段将易挥发的香料分子与不易挥发的前体通过共价键结合在一起,在特定的条件下选择性的发生化学键断裂从而释放出香料活性分子,该过程是可控并且连续发生的。化学键断裂的条件包括光照、氧化、加热、水解、改变pH及酶催化等,均广泛存在于自然界及人类日常生活当中。水作为一种常见溶剂,常用于各种加香产品中,而通过水解或者改变pH的方式来控制香料分子的释放已被许多文献所报道。腙类化合物与席夫碱类似,可在酸性水溶液中水解释放出醛酮类香料分子。同时相较于席夫碱,腙类化合物的稳定性更好,不会快速发生水解。吡啶季铵盐酰肼化合物与芳香醛酮反应得到吡啶季铵盐腙类化合物,可在酸性条件下水解释放出芳香醛酮分子。潜香体在水解释放香料分子后留在水溶液体系中的化合物大多无用,因此,合成一种水溶性较好,释放香料后留在溶液体系中的物质同样具有多种作用的潜香体化合物成为需要解决的技术问题。At present, there are many methods for fragrance slow release. The method of delaying fragrance release by using latent fragrance body is to use chemical means to combine volatile fragrance molecules with non-volatile precursors through covalent bonds, and selectively release fragrance under specific conditions. The chemical bond breaking that releases the fragrance active molecules occurs in a controlled and continuous manner. The conditions for breaking chemical bonds include light, oxidation, heating, hydrolysis, changing pH and enzyme catalysis, etc., which are widely found in nature and human daily life. As a common solvent, water is often used in various flavoring products, and the release of fragrance molecules by hydrolysis or changing the pH has been reported in many literatures. Hydrazone compounds are similar to Schiff bases, which can be hydrolyzed in acidic aqueous solution to release aldehydes and ketones fragrance molecules. At the same time, compared with Schiff bases, hydrazone compounds are more stable and will not undergo rapid hydrolysis. The pyridinium quaternary ammonium salt hydrazide compound reacts with aromatic aldehydes and ketones to obtain pyridinium quaternary ammonium salt hydrazone compounds, which can be hydrolyzed under acidic conditions to release aromatic aldehydes and ketone molecules. Most of the latent fragrance compounds left in the aqueous system after hydrolysis to release the fragrance molecules are useless. Therefore, a kind of latent fragrance compound with good water solubility and the same substances that remain in the solution system after releasing the fragrance has multiple functions becomes Technical issues that need to be resolved.
发明内容Contents of the invention
本发明的第一个目的是提供一种吡啶季铵盐腙类化合物。The first object of the present invention is to provide a kind of pyridine quaternary ammonium salt hydrazone compound.
本发明的第二个目的是提供一种所述吡啶季铵盐腙类化合物的制备方法。The second object of the present invention is to provide a method for preparing the pyridine quaternary ammonium hydrazone compound.
本发明的第三个目的是提供一种所述吡啶季铵盐腙类化合物在抗菌或香料缓释中的应用。The third object of the present invention is to provide an application of the pyridinium quaternary ammonium salt hydrazone compound in antibacterial or perfume sustained release.
为了实现上述目的,本发明采用的技术方案如下:In order to achieve the above object, the technical scheme adopted in the present invention is as follows:
本发明的第一个方面提供了一种吡啶季铵盐型腙类化合物,具有以下所示结构:The first aspect of the present invention provides a pyridine quaternary ammonium salt type hydrazone compound, which has the following structure:
R1选自氢、C1-C20烷基;R 1 is selected from hydrogen, C 1 -C 20 alkyl;
R2选自氢、取代或未取代的芳基、C1-C20链烯基取代的芳基、取代或未取代的环烷基或杂环基;R 2 is selected from hydrogen, substituted or unsubstituted aryl, C 1 -C 20 alkenyl substituted aryl, substituted or unsubstituted cycloalkyl or heterocyclyl;
R3选自氢、C1-C20烷基;R 3 is selected from hydrogen, C 1 -C 20 alkyl;
R4选自氢、C1-C20烷基;R 4 is selected from hydrogen, C 1 -C 20 alkyl;
X为卤素(F、Cl、Br或I)。X is halogen (F, Cl, Br or I).
较优选的,所述吡啶季铵盐型腙类化合物中,More preferably, in the pyridine quaternary ammonium salt type hydrazone compound,
R1选自氢、C5-C18烷基;R 1 is selected from hydrogen, C 5 -C 18 alkyl;
R2选自氢、取代或未取代的苯基、取代或未取代的苯并杂环、C1-C20链烯基取代的苯基、取代或未取代的环己烯、取代或未取代的环烷基;R 2 is selected from hydrogen, substituted or unsubstituted phenyl, substituted or unsubstituted benzoheterocycle, C 1 -C 20 alkenyl substituted phenyl, substituted or unsubstituted cyclohexene, substituted or unsubstituted Cycloalkyl;
R3选自氢、C5-C18烷基;R 3 is selected from hydrogen, C 5 -C 18 alkyl;
R4选自氢、C5-C18烷基;R 4 is selected from hydrogen, C 5 -C 18 alkyl;
X为Cl、Br。X is Cl, Br.
更优选的,所述吡啶季铵盐型腙类化合物中,More preferably, in the pyridine quaternary ammonium salt type hydrazone compound,
R1选自氢、C5-C18烷基;R 1 is selected from hydrogen, C 5 -C 18 alkyl;
R2选自氢、 R 2 is selected from hydrogen,
R3选自氢、甲基;R 3 is selected from hydrogen, methyl;
R4选自氢、甲基;R 4 is selected from hydrogen, methyl;
X为Br。X is Br.
最优选的,所述吡啶季铵盐型腙类化合物为以下结构中的一种:Most preferably, the pyridine quaternary ammonium hydrazone compound is one of the following structures:
本发明的第二个方面提供了一种所述吡啶季铵盐型腙类化合物的制备方法,包括以下步骤:A second aspect of the present invention provides a method for preparing the pyridine quaternary ammonium hydrazone compound, comprising the following steps:
将3-羟基吡啶溶于溶剂中,加入碱,温度为20~60℃的条件下反应0.1~48h,滴加卤代烷,3-羟基吡啶、碱、溴代烷的摩尔比为1:(2~30):1,反应完全后获得中间体吡啶化合物;Dissolve 3-hydroxypyridine in a solvent, add alkali, react at a temperature of 20-60°C for 0.1-48 hours, add haloalkane dropwise, the molar ratio of 3-hydroxypyridine, alkali, and bromoalkane is 1:(2~ 30): 1, the intermediate pyridine compound is obtained after the reaction is complete;
将中间体吡啶化合物溶于溶剂中,加入卤代乙酸乙酯,中间体吡啶化合物与卤代乙酸乙酯的摩尔比为1:(1.1~2),温度为20~60℃的条件下反应0.1~48h,得到吡啶季铵盐化合物;Dissolve the intermediate pyridine compound in the solvent, add ethyl haloacetate, the molar ratio of the intermediate pyridine compound to ethyl haloacetate is 1:(1.1~2), and react at a temperature of 20~60°C for 0.1 ~48h, to obtain the pyridinium quaternary ammonium salt compound;
将水合肼溶于溶剂中,将吡啶季铵盐化合物溶于溶剂中,缓慢加入到上述水合肼的溶液中,水合肼与吡啶季铵盐化合物的摩尔比为(5~15):1,温度为20~60℃的条件下反应0.1~48h,得到吡啶季铵盐酰肼化合物;Dissolve hydrazine hydrate in the solvent, dissolve the pyridinium quaternary ammonium compound in the solvent, and slowly add it to the solution of the above-mentioned hydrazine hydrate, the molar ratio of hydrazine hydrate to the pyridinium quaternary ammonium compound is (5~15):1, the temperature Reaction under the condition of 20-60°C for 0.1-48 hours to obtain pyridinium quaternary ammonium hydrazide compound;
将摩尔比为1:(1.1~2)的吡啶季铵盐型酰肼化合物与醛或酮类香料溶于溶剂中,回流反应,获得所述吡啶季铵盐型腙类化合物。The pyridine quaternary ammonium salt type hydrazide compound with a molar ratio of 1:(1.1-2) and aldehyde or ketone spices are dissolved in a solvent and reacted under reflux to obtain the pyridine quaternary ammonium salt type hydrazone compound.
所述溶剂为二甲基亚砜、乙酸乙酯、乙醇。Described solvent is dimethyl sulfoxide, ethyl acetate, ethanol.
所述碱为氢氧化钾、氢氧化钠。Described alkali is potassium hydroxide, sodium hydroxide.
所述卤代烷为溴代十二烷、溴代辛烷、溴代癸烷、溴代十四烷、溴代十六烷、溴代乙烷、溴代丙烷、溴代丁烷、溴代戊烷、溴代己烷、溴代庚烷、溴代壬烷。The haloalkane is bromododecane, bromooctane, bromodecane, bromotetradecane, bromohexadecane, bromoethane, bromopropane, bromobutane, bromopentane , bromohexane, bromoheptane, bromononane.
所述卤代乙酸乙酯为溴乙酸乙酯。The ethyl haloacetate is ethyl bromoacetate.
所述醛或酮类香料为肉桂醛、新洋茉莉醛、β-紫罗兰酮、兔耳草醛、苯甲醛、茴香醛、香草醛、香茅醛、紫罗兰酮、甲基紫罗兰酮、香芹酮、大马酮。The aldehyde or ketone fragrance is cinnamaldehyde, jasminaldehyde, β-ionone, rabbit ear oxalin, benzaldehyde, anisaldehyde, vanillin, citronellal, ionone, methyl ionone, carvone , Damascenone.
本发明的第三个方面提供了一种所述吡啶季铵盐型腙类化合物在抗菌或香料缓释中的应用。The third aspect of the present invention provides an application of the pyridinium quaternary ammonium salt type hydrazone compound in antibacterial or fragrance sustained release.
本发明的第四个方面提供了一种所述吡啶季铵盐型腙类化合物作为抗菌剂或香料缓释剂的用途。The fourth aspect of the present invention provides a use of the pyridinium quaternary ammonium hydrazone compound as an antibacterial agent or perfume slow-release agent.
由于采用上述技术方案,本发明具有以下优点和有益效果:Owing to adopting above-mentioned technical scheme, the present invention has following advantage and beneficial effect:
本发明带有长碳链的吡啶季铵盐腙类化合物,对它进行了一系列的性能测试及表征,具有良好的水溶性,可在酸性水溶液中水解释放芳香醛酮物质,通过动态平衡达到实现香料缓慢释放的目的。同时,水解之后留在溶液体系中的吡啶季铵盐型酰肼化合物依然具有良好的表面活性及抗菌能力,是一种多功能的表面活性剂,这在实际应用中具有一定的积极意义。The pyridine quaternary ammonium salt hydrazone compounds with long carbon chains of the present invention have been subjected to a series of performance tests and characterizations, have good water solubility, can be hydrolyzed in acidic aqueous solution to release aromatic aldehydes and ketones, and can be achieved through dynamic equilibrium. To achieve the purpose of slow release of spices. At the same time, the pyridine quaternary ammonium salt type hydrazide compound remaining in the solution system after hydrolysis still has good surface activity and antibacterial ability, and is a multifunctional surfactant, which has certain positive significance in practical applications.
附图说明Description of drawings
图1是吡啶季铵盐酰肼化合物的表面张力-浓度曲线示意图。Fig. 1 is a schematic diagram of the surface tension-concentration curve of pyridinium quaternary ammonium salt hydrazide compound.
图2是吡啶季铵盐腙类化合物A和纯香料物质释放芳香物质的时间-峰面积曲线示意图。Fig. 2 is a schematic diagram of time-peak area curves of pyridine quaternary ammonium hydrazone compound A and pure fragrance substances releasing aromatic substances.
图3是吡啶季铵盐腙类化合物B和纯香料物质释放芳香物质的时间-峰面积曲线示意图。Fig. 3 is a schematic diagram of time-peak area curves of pyridine quaternary ammonium hydrazone compound B and pure fragrance substances releasing aromatic substances.
图4是吡啶季铵盐腙类化合物C和纯香料物质释放芳香物质的时间-峰面积曲线示意图。Fig. 4 is a schematic diagram of time-peak area curves of pyridine quaternary ammonium hydrazone compound C and pure fragrance substances releasing aromatic substances.
图5是吡啶季铵盐腙类化合物D和纯香料物质释放芳香物质的时间-峰面积曲线示意图。Fig. 5 is a schematic diagram of time-peak area curves of pyridine quaternary ammonium hydrazone compound D and pure fragrance substances releasing aromatic substances.
具体实施方式Detailed ways
为了更清楚地说明本发明,下面结合优选实施例对本发明做进一步的说明。本领域技术人员应当理解,下面所具体描述的内容是说明性的而非限制性的,不应以此限制本发明的保护范围。In order to illustrate the present invention more clearly, the present invention will be further described below in conjunction with preferred embodiments. Those skilled in the art should understand that the content specifically described below is illustrative rather than restrictive, and should not limit the protection scope of the present invention.
实施例1Example 1
吡啶季铵盐腙类化合物的制备方法包括以下步骤:The preparation method of pyridine quaternary ammonium hydrazone compound comprises the following steps:
(1)将10mmol 3-羟基吡啶置于烧瓶中,加入10mL二甲基亚砜溶解。将2.7g KOH加入到烧瓶中,温度为35℃的条件下搅拌30分钟,滴加10mmol溴代十二烷,反应过夜,反应结束后加入饱和氯化铵水溶液水洗,用二氯甲烷萃取,合并萃取液,以石油醚/乙酸乙酯作为洗脱剂,柱层析后得到浅黄色固体中间体吡啶化合物,产率为53%。(1) Put 10mmol of 3-hydroxypyridine in a flask and add 10mL of dimethyl sulfoxide to dissolve it. Add 2.7g KOH into the flask, stir for 30 minutes at 35°C, add 10mmol dodecane bromide dropwise, and react overnight. After the reaction, add saturated ammonium chloride aqueous solution to wash with water, extract with dichloromethane, and combine The extract was chromatographed with petroleum ether/ethyl acetate as an eluent to obtain a light yellow solid intermediate pyridine compound with a yield of 53%.
(2)将1mmol上述中间体吡啶化合物置于烧瓶中,加入10mL乙酸乙酯溶解,加入1.2mmol溴乙酸乙酯,温度为50℃的条件下回流24小时,反应结束后冷却有固体析出,过滤并用正己烷重结晶,得白色固体产物吡啶季铵盐化合物,产率为96%。(2) Put 1 mmol of the above-mentioned intermediate pyridine compound in a flask, add 10 mL of ethyl acetate to dissolve, add 1.2 mmol of ethyl bromoacetate, and reflux for 24 hours at a temperature of 50 ° C. After the reaction is completed, solids precipitate out after cooling, and filter and recrystallized with n-hexane to obtain a white solid product pyridinium quaternary ammonium salt compound with a yield of 96%.
(3)将10mmol水合肼置于烧瓶中,加入15mL无水乙醇溶解。将1mmol上述吡啶季铵盐化合物溶于10mL无水乙醇中,缓慢加入到上述水合肼的乙醇溶液中,温度为50℃的条件下反应四个小时。反应结束后,减压蒸馏旋掉部分乙醇,放入冰箱中冷却过夜,析出结晶,过滤晶体并用冰乙醇进行洗涤,得吡啶季铵盐酰肼化合物,白色固体,产率为63%。(3) Put 10mmol of hydrazine hydrate in a flask and add 15mL of absolute ethanol to dissolve it. 1 mmol of the above-mentioned pyridinium quaternary ammonium salt compound was dissolved in 10 mL of absolute ethanol, slowly added to the ethanol solution of the above-mentioned hydrazine hydrate, and reacted for four hours at a temperature of 50° C. After the reaction, part of the ethanol was distilled off under reduced pressure, cooled overnight in a refrigerator, and crystals were precipitated, filtered and washed with ice ethanol to obtain pyridine quaternary ammonium hydrazide compound, a white solid, with a yield of 63%.
(4)向圆底烧瓶中加入0.8mmol吡啶季铵盐酰肼化合物,加入1.2mmol肉桂醛,加入15mL乙醇作为溶剂回流4h,反应结束后冷却至室温,以二氯甲烷/甲醇作为洗脱剂,经柱层析后得到浅黄色目标产物(结构如式A所示),产率为50%。(4) Add 0.8mmol of pyridinium quaternary ammonium hydrazide compound to the round bottom flask, add 1.2mmol of cinnamaldehyde, add 15mL of ethanol as solvent and reflux for 4h, cool to room temperature after the reaction, use dichloromethane/methanol as eluent , the light yellow target product (structure shown in formula A) was obtained after column chromatography, and the yield was 50%.
1H NMR(400MHz,CDCl3)δ12.40(s,1H),9.03(s,1H),8.82(d,J=5.4Hz,1H),8.19(d,J=8.7Hz,1H),7.82(dd,J=13.9,8.3Hz,2H),7.34–7.29(m,2H),7.24(d,J=7.5Hz,3H),6.82(m,J=16.0,12.4Hz,2H),5.90(s,2H),4.12(t,J=6.3Hz,2H),1.75–1.68(m,2H),1.18(s,18H),0.80(t,J=6.8Hz,3H). 1 H NMR (400MHz, CDCl 3 ) δ12.40(s, 1H), 9.03(s, 1H), 8.82(d, J=5.4Hz, 1H), 8.19(d, J=8.7Hz, 1H), 7.82 (dd,J=13.9,8.3Hz,2H),7.34–7.29(m,2H),7.24(d,J=7.5Hz,3H),6.82(m,J=16.0,12.4Hz,2H),5.90( s,2H),4.12(t,J=6.3Hz,2H),1.75–1.68(m,2H),1.18(s,18H),0.80(t,J=6.8Hz,3H).
13C NMR(101MHz,CDCl3)δ159.29,157.07,151.59,140.81,137.39,134.58,131.27,131.21,128.28,127.81,127.01,126.27,123.45,76.39,76.07,75.75,70.36,60.55,30.89,28.63,28.61,28.56,28.47,28.33,28.27,27.67,24.73,21.67,13.12. 13 C NMR(101MHz,CDCl 3 )δ159.29,157.07,151.59,140.81,137.39,134.58,131.27,131.21,128.28,127.81,127.01,126.27,123.45,76.39,76.07,75.75,70.36,60.55,30.89,28.63,28.61 ,28.56,28.47,28.33,28.27,27.67,24.73,21.67,13.12.
HRMS(ESI-TOF)m/z:[M-Br]+Calcd for C28H40N3O2 450.3115;Found 450.3120.HRMS (ESI-TOF) m/z: [M-Br]+Calcd for C 28 H 40 N 3 O 2 450.3115; Found 450.3120.
实施例2Example 2
吡啶季铵盐腙类化合物的制备方法包括以下步骤:The preparation method of pyridine quaternary ammonium hydrazone compound comprises the following steps:
除将实施例1步骤(4)中的肉桂醛改为新洋茉莉醛外,其余条件均与实施例1中相同,得式B所示化合物。Except that the cinnamaldehyde in step (4) of Example 1 was changed to jasmonal, all the other conditions were the same as in Example 1 to obtain the compound shown in formula B.
1H NMR(400MHz,CDCl3)δ12.28(s,1H),9.07(s,1H),8.83(s,1H),7.87(d,J=2.3Hz,2H),7.83(d,J=6.2Hz,1H),6.67(d,J=7.8Hz,1H),6.60(d,J=1.4Hz,1H),6.56(m,J=7.9,1.5Hz,1H),5.87(s,2H),5.82(d,J=6.9Hz,2H),4.21(t,J=6.2Hz,3H),2.81(m,J=13.5,5.9Hz,2H),2.70–2.59(m,2H),2.44(m,J=13.6,8.7Hz,2H),1.80(m,J=14.6,6.6Hz,2H),1.23(s,18H),1.01–0.98(d,3H),0.85(t,J=6.8Hz,3H). 1 H NMR (400MHz, CDCl 3 ) δ12.28(s, 1H), 9.07(s, 1H), 8.83(s, 1H), 7.87(d, J=2.3Hz, 2H), 7.83(d, J= 6.2Hz, 1H), 6.67(d, J=7.8Hz, 1H), 6.60(d, J=1.4Hz, 1H), 6.56(m, J=7.9, 1.5Hz, 1H), 5.87(s, 2H) ,5.82(d,J=6.9Hz,2H),4.21(t,J=6.2Hz,3H),2.81(m,J=13.5,5.9Hz,2H),2.70–2.59(m,2H),2.44( m,J=13.6,8.7Hz,2H),1.80(m,J=14.6,6.6Hz,2H),1.23(s,18H),1.01–0.98(d,3H),0.85(t,J=6.8Hz ,3H).
13C NMR(101MHz,CDCl3)δ158.92,158.24,157.14,146.50,144.87,137.17,132.28,131.95,131.24,131.17,126.94,121.15,108.46,107.14,99.78,76.40,76.08,75.76,70.38,60.47,38.88,37.97,30.89,28.63,28.61,28.55,28.47,28.33,28.25,27.67,24.74,21.67,15.85,13.12. 13 C NMR(101MHz,CDCl 3 )δ158.92,158.24,157.14,146.50,144.87,137.17,132.28,131.95,131.24,131.17,126.94,121.15,108.46,107.14,99.78,76.40,76.08,75.76,70.38,60.47,38.88 ,37.97,30.89,28.63,28.61,28.55,28.47,28.33,28.25,27.67,24.74,21.67,15.85,13.12.
HRMS(ESI-TOF)m/z:[M-Br]+Calcd for C30H44N3O4 510.3326;Found 510.3333.HRMS (ESI-TOF) m/z: [M-Br]+Calcd for C 30 H 44 N 3 O 4 510.3326; Found 510.3333.
实施例3Example 3
吡啶季铵盐腙类化合物的制备方法包括以下步骤:The preparation method of pyridine quaternary ammonium hydrazone compound comprises the following steps:
除将实施例1步骤(4)中的肉桂醛改为β-紫罗兰酮外,其余条件均与实施例1中相同,得式C所示化合物。Except that the cinnamaldehyde in the step (4) of Example 1 was changed to β-ionone, the other conditions were the same as in Example 1 to obtain the compound shown in Formula C.
1H NMR(400MHz,CDCl3)δ11.29(s,1H),9.29(s,1H),8.93(s,1H),7.89–7.80(d2H),6.62(d,J=16.5Hz,1H),6.23(d,J=16.5Hz,1H),6.13(s,2H),4.22(t,J=6.3Hz,2H),2.33(s,3H),1.97(t,J=6.1Hz,2H),1.85–1.76(m,3H),1.63(s,3H),1.60–1.54(m,2H),1.44–1.42(m,2H),1.23(s,18H),0.97(s,6H),0.84(t,J=6.8Hz,3H). 1 H NMR (400MHz, CDCl 3 )δ11.29(s,1H),9.29(s,1H),8.93(s,1H),7.89–7.80(d2H),6.62(d,J=16.5Hz,1H) ,6.23(d,J=16.5Hz,1H),6.13(s,2H),4.22(t,J=6.3Hz,2H),2.33(s,3H),1.97(t,J=6.1Hz,2H) ,1.85–1.76(m,3H),1.63(s,3H),1.60–1.54(m,2H),1.44–1.42(m,2H),1.23(s,18H),0.97(s,6H),0.84 (t,J=6.8Hz,3H).
13C NMR(101MHz,CDCl3)δ159.89,157.61,157.13,137.25,135.62,134.76,131.45,131.31,131.17,130.89,126.79,76.41,76.09,75.77,70.44,60.34,38.52,33.09,32.06,30.90,28.63,28.61,28.55,28.47,28.33,28.24,27.81,27.67,24.74,21.67,20.67,18.02. 13 C NMR(101MHz,CDCl 3 )δ159.89,157.61,157.13,137.25,135.62,134.76,131.45,131.31,131.17,130.89,126.79,76.41,76.09,75.77,70.44,60.34,38.52,33.09,32.06,30.90,28.63 ,28.61,28.55,28.47,28.33,28.24,27.81,27.67,24.74,21.67,20.67,18.02.
HRMS(ESI-TOF)m/z:[M-Br]+Calcd for C32H52N3O2 510.4054;Found510.4059.HRMS (ESI-TOF) m/z: [M-Br]+Calcd for C 32 H 52 N 3 O 2 510.4054; Found 510.4059.
实施例4Example 4
吡啶季铵盐腙类化合物的制备方法包括以下步骤:The preparation method of pyridine quaternary ammonium hydrazone compound comprises the following steps:
除将实施例1步骤(4)中的肉桂醛改为兔耳草醛外,其余条件均与实施例1中相同,得式D所示化合物。Except that the cinnamaldehyde in step (4) of Example 1 was changed to oxalin, all the other conditions were the same as in Example 1 to obtain the compound shown in formula D.
1H NMR(400MHz,CDCl3)δ12.29(s,1H),9.10(s,1H),8.84(s,J=2.8Hz,1H),7.87(d,J=6.5Hz,2H),7.85(d,J=0.9Hz,1H),7.11(d,J=8.0Hz,2H),7.04(d,J=8.1Hz,2H),5.85(d,J=6.7Hz,2H),4.22(t,J=6.3Hz,2H),2.92–2.78(m,3H),2.74–2.65(m,1H),2.47(m,J=13.5,9.1Hz,1H),1.81(m,J=14.7,6.6Hz,2H),1.24(s,18H),1.20(d,J=6.9Hz,6H),1.00(d,J=6.8Hz,3H),0.86(t,J=6.8Hz,3H). 1 H NMR (400MHz, CDCl 3 )δ12.29(s,1H),9.10(s,1H),8.84(s,J=2.8Hz,1H),7.87(d,J=6.5Hz,2H),7.85 (d, J=0.9Hz, 1H), 7.11(d, J=8.0Hz, 2H), 7.04(d, J=8.1Hz, 2H), 5.85(d, J=6.7Hz, 2H), 4.22(t ,J=6.3Hz,2H),2.92–2.78(m,3H),2.74–2.65(m,1H),2.47(m,J=13.5,9.1Hz,1H),1.81(m,J=14.7,6.6 Hz, 2H), 1.24(s, 18H), 1.20(d, J=6.9Hz, 6H), 1.00(d, J=6.8Hz, 3H), 0.86(t, J=6.8Hz, 3H).
13C NMR(101MHz,CDCl3)δ158.87,158.54,157.16,145.67,137.11,135.45,131.25,131.14,128.10,126.91,125.40,76.40,76.08,75.76,70.40,60.46,38.70,37.78,32.65,30.89,28.63,28.61,28.55,28.47,28.33,28.24,27.66,24.74,23.00,21.67,15.85,13.12. 13 C NMR(101MHz,CDCl 3 )δ158.87,158.54,157.16,145.67,137.11,135.45,131.25,131.14,128.10,126.91,125.40,76.40,76.08,75.76,70.40,60.46,38.70,37.78,32.65,30.89,28.63 ,28.61,28.55,28.47,28.33,28.24,27.66,24.74,23.00,21.67,15.85,13.12.
HRMS(ESI-TOF)m/z:[M-Br]+Calcd for C32H50N3O2 508.3898;Found 508.3904.HRMS(ESI-TOF) m/z: [M-Br]+Calcd for C 32 H 50 N 3 O 2 508.3898; Found 508.3904.
实施例5Example 5
吡啶季铵盐腙类化合物的制备方法包括以下步骤:The preparation method of pyridine quaternary ammonium hydrazone compound comprises the following steps:
除将实施例1步骤(1)中的溴代十二烷改为溴代辛烷,实施例1步骤(4)中的肉桂醛改为新洋茉莉醛外,其余条件均与实施例1中相同,得式E所示化合物。Except changing the bromododecane in the embodiment 1 step (1) into bromooctane, and changing the cinnamaldehyde in the embodiment 1 step (4) into new jasmonal, all the other conditions are the same as in the embodiment 1 Same, the compound shown in formula E is obtained.
1H NMR(400MHz,CDCl3)δ12.32(s,1H),9.10(s,1H),8.83(s,1H),7.86(d,J=3.0Hz,2H),7.83(d,J=6.2Hz,1H),6.67(d,J=7.8Hz,1H),6.60(d,J=1.4Hz,1H),6.56(dd,J=7.9,1.5Hz,1H),5.87(s,2H),5.82(d,J=7.3Hz,2H),4.21(t,J=6.2Hz,2H),2.81(m,J=13.6,5.8Hz,1H),2.65(m,J=10.6,4.2Hz,1H),2.43(m,J=13.6,8.7Hz,2H),1.80(m,J=14.7,6.6Hz,2H),1.25(s,J=1.8Hz,10H),0.99(d,J=6.8Hz,3H),0.89–0.76(t,3H). 1 H NMR (400MHz, CDCl 3 ) δ12.32(s, 1H), 9.10(s, 1H), 8.83(s, 1H), 7.86(d, J=3.0Hz, 2H), 7.83(d, J= 6.2Hz, 1H), 6.67(d, J=7.8Hz, 1H), 6.60(d, J=1.4Hz, 1H), 6.56(dd, J=7.9, 1.5Hz, 1H), 5.87(s, 2H) ,5.82(d,J=7.3Hz,2H),4.21(t,J=6.2Hz,2H),2.81(m,J=13.6,5.8Hz,1H),2.65(m,J=10.6,4.2Hz, 1H), 2.43(m, J=13.6, 8.7Hz, 2H), 1.80(m, J=14.7, 6.6Hz, 2H), 1.25(s, J=1.8Hz, 10H), 0.99(d, J=6.8 Hz,3H),0.89–0.76(t,3H).
13C NMR(101MHz,CDCl3)δ158.88,158.24,157.16,146.50,144.87,137.09,131.94,131.24,131.17,126.94,121.14,108.45,107.14,99.77,76.40,76.08,75.77,70.40,60.45,38.88,37.96,30.72,28.68,28.17,28.11,27.65,24.72,21.61,15.85,13.08. 13 C NMR(101MHz,CDCl 3 )δ158.88,158.24,157.16,146.50,144.87,137.09,131.94,131.24,131.17,126.94,121.14,108.45,107.14,99.77,76.40,76.08,75.77,70.40,60.45,38.88,37.96 ,30.72,28.68,28.17,28.11,27.65,24.72,21.61,15.85,13.08.
HRMS(ESI-TOF)m/z:[M-Br]+Calcd for C26H36N3O4 454.2700;Found 454.2707.HRMS (ESI-TOF) m/z: [M-Br]+Calcd for C 26 H 36 N 3 O 4 454.2700; Found 454.2707.
实施例6Example 6
吡啶季铵盐腙类化合物的制备方法包括以下步骤:The preparation method of pyridine quaternary ammonium hydrazone compound comprises the following steps:
除将实施例1步骤(1)中的溴代十二烷改为溴代癸烷,实施例1步骤(4)中的肉桂醛改为新洋茉莉醛外,其余条件均与实施例1中相同,得式F所示化合物。Except that the bromododecane in the embodiment 1 step (1) is changed into bromodecane, and the cinnamaldehyde in the embodiment 1 step (4) is changed into new ocean jasmonal, all the other conditions are all the same as in the embodiment 1 Same, the compound shown in formula F is obtained.
1H NMR(400MHz,CDCl3)δ12.30(s,1H),9.09(s,1H),8.83(s,1H),7.86(d,J=3.1Hz,2H),7.83(d,J=6.2Hz,1H),6.67(d,J=7.8Hz,1H),6.60(d,J=1.4Hz,1H),6.56(m,J=7.9,1.5Hz,1H),5.87(s,2H),5.83(d,J=7.3Hz,2H),4.22(t,J=6.2Hz,3H),2.82(m,J=13.6,5.9Hz,1H),2.64(m,J=13.9,7.3Hz,1H),2.44(m,J=13.6,8.7Hz,1H),1.87–1.75(m,2H),1.24(s,14H),1.00(d,J=6.8Hz,3H),0.85(t,J=6.8Hz,3H). 1 H NMR (400MHz, CDCl 3 ) δ12.30(s, 1H), 9.09(s, 1H), 8.83(s, 1H), 7.86(d, J=3.1Hz, 2H), 7.83(d, J= 6.2Hz, 1H), 6.67(d, J=7.8Hz, 1H), 6.60(d, J=1.4Hz, 1H), 6.56(m, J=7.9, 1.5Hz, 1H), 5.87(s, 2H) ,5.83(d,J=7.3Hz,2H),4.22(t,J=6.2Hz,3H),2.82(m,J=13.6,5.9Hz,1H),2.64(m,J=13.9,7.3Hz, 1H), 2.44(m, J=13.6, 8.7Hz, 1H), 1.87–1.75(m, 2H), 1.24(s, 14H), 1.00(d, J=6.8Hz, 3H), 0.85(t, J =6.8Hz,3H).
13C NMR(101MHz,CDCl3)δ158.88,158.25,157.16,146.51,144.87,137.11,131.94,131.24,131.17,126.92,121.15,108.46,107.14,99.78,76.40,76.08,75.76,70.40,60.46,38.88,37.97,30.85,28.49,28.46,28.28,28.23,27.66,24.73,21.65,15.86,13.11. 13 C NMR(101MHz,CDCl 3 )δ158.88,158.25,157.16,146.51,144.87,137.11,131.94,131.24,131.17,126.92,121.15,108.46,107.14,99.78,76.40,76.08,75.76,70.40,60.46,38.88,37.97 ,30.85,28.49,28.46,28.28,28.23,27.66,24.73,21.65,15.86,13.11.
HRMS(ESI-TOF)m/z:[M-Br]+Calcd for C28H40N3O4 482.3013;Found 482.3020.HRMS (ESI-TOF) m/z: [M-Br]+Calcd for C 28 H 40 N 3 O 4 482.3013; Found 482.3020.
实施例7Example 7
吡啶季铵盐腙类化合物的制备方法包括以下步骤:The preparation method of pyridine quaternary ammonium hydrazone compound comprises the following steps:
除将实施例1步骤(1)中的溴代十二烷改为溴代十四烷,实施例1步骤(4)中的肉桂醛改为新洋茉莉醛外,其余条件均与实施例1中相同,得式G所示化合物。Except changing the bromododecane in the embodiment 1 step (1) into bromotetradecane, and changing the cinnamaldehyde in the embodiment 1 step (4) into new jasmonal, all the other conditions are the same as in the embodiment 1 In the same way, the compound shown in formula G is obtained.
1H NMR(400MHz,CDCl3)δ12.28(s,1H),9.08(s,1H),8.83(s,1H),7.86(d,J=3.1Hz,2H),7.83(d,J=6.2Hz,1H),6.67(d,J=7.8Hz,1H),6.59(d,J=1.5Hz,1H),6.55(m,J=7.9,1.6Hz,1H),5.87(s,2H),5.83(d,J=7.2Hz,2H),4.21(t,J=6.2Hz,3H),2.81(m,J=13.5,5.9Hz,1H),2.64(m,J=19.3,6.4Hz,1H),2.43(m,J=13.6,8.7Hz,1H),1.87–1.67(m,2H),1.23(s,22H),0.99(d,J=6.8Hz,3H),0.85(t,J=6.8Hz,3H). 1 H NMR (400MHz, CDCl 3 ) δ12.28(s, 1H), 9.08(s, 1H), 8.83(s, 1H), 7.86(d, J=3.1Hz, 2H), 7.83(d, J= 6.2Hz, 1H), 6.67(d, J=7.8Hz, 1H), 6.59(d, J=1.5Hz, 1H), 6.55(m, J=7.9, 1.6Hz, 1H), 5.87(s, 2H) ,5.83(d,J=7.2Hz,2H),4.21(t,J=6.2Hz,3H),2.81(m,J=13.5,5.9Hz,1H),2.64(m,J=19.3,6.4Hz, 1H), 2.43(m, J=13.6, 8.7Hz, 1H), 1.87–1.67(m, 2H), 1.23(s, 22H), 0.99(d, J=6.8Hz, 3H), 0.85(t, J =6.8Hz,3H).
13C NMR(101MHz,CDCl3)δ158.92,158.20,157.13,146.50,144.87,137.15,131.94,131.23,131.18,126.93,121.15,108.45,107.14,99.78,76.41,76.09,75.78,70.39,60.45,38.88,37.97,30.90,28.67,28.64,28.56,28.48,28.34,28.25,27.67,24.74,21.67,15.86,13.12. 13 C NMR(101MHz,CDCl 3 )δ158.92,158.20,157.13,146.50,144.87,137.15,131.94,131.23,131.18,126.93,121.15,108.45,107.14,99.78,76.41,76.09,75.78,70.39,60.45,38.88,37.97 ,30.90,28.67,28.64,28.56,28.48,28.34,28.25,27.67,24.74,21.67,15.86,13.12.
HRMS(ESI-TOF)m/z:[M-Br]+Calcd for C32H48N3O4 538.3639;Found 538.3646.HRMS (ESI-TOF) m/z: [M-Br]+Calcd for C 32 H 48 N 3 O 4 538.3639; Found 538.3646.
实施例8Example 8
吡啶季铵盐腙类化合物的制备方法包括以下步骤:The preparation method of pyridine quaternary ammonium hydrazone compound comprises the following steps:
除将实施例1步骤(1)中的溴代十二烷改为溴代十六烷,实施例1步骤(4)中的肉桂醛改为新洋茉莉醛外,其余条件均与实施例1中相同,得式H所示化合物。Except changing dodecane bromide in embodiment 1 step (1) into hexadecane bromide, cinnamaldehyde in embodiment 1 step (4) is changed into new ocean jasmonal, all the other conditions are all the same as embodiment 1 In the same way, the compound shown in formula H is obtained.
1H NMR(400MHz,CDCl3)δ12.29(s,1H),9.09(s,1H),8.83(s,1H),7.86(d,J=3.1Hz,2H),7.83(d,J=6.2Hz,1H),6.67(d,J=7.8Hz,1H),6.60(d,J=1.4Hz,1H),6.56(dd,J=7.9,1.5Hz,1H),5.88(s,2H),5.83(d,J=7.4Hz,2H),4.22(t,J=6.2Hz,3H),2.82(m,J=13.5,5.9Hz,1H),2.65(m,J=12.9,6.4Hz,1H),2.44(m,J=13.6,8.7Hz,1H),1.87–1.76(m,2H),1.23(s,26H),1.00(d,J=6.8Hz,3H),0.85(t,J=6.8Hz,3H). 1 H NMR (400MHz, CDCl 3 ) δ12.29(s, 1H), 9.09(s, 1H), 8.83(s, 1H), 7.86(d, J=3.1Hz, 2H), 7.83(d, J= 6.2Hz, 1H), 6.67(d, J=7.8Hz, 1H), 6.60(d, J=1.4Hz, 1H), 6.56(dd, J=7.9, 1.5Hz, 1H), 5.88(s, 2H) ,5.83(d,J=7.4Hz,2H),4.22(t,J=6.2Hz,3H),2.82(m,J=13.5,5.9Hz,1H),2.65(m,J=12.9,6.4Hz, 1H), 2.44(m, J=13.6, 8.7Hz, 1H), 1.87–1.76(m, 2H), 1.23(s, 26H), 1.00(d, J=6.8Hz, 3H), 0.85(t, J =6.8Hz,3H).
13C NMR(101MHz,CDCl3)δ160.01,159.35,158.25,147.59,145.96,138.21,133.02,132.33,132.24,127.99,122.24,109.54,108.23,100.86,77.48,77.16,76.84,71.44,61.55,39.97,39.06,31.99,29.77,29.73,29.65,29.57,29.43,29.34,28.76,25.83,22.76,16.95,14.20. 13 C NMR(101MHz,CDCl 3 )δ160.01,159.35,158.25,147.59,145.96,138.21,133.02,132.33,132.24,127.99,122.24,109.54,108.23,100.86,77.48,77.16,76.84,71.44,61.55,39.97,39.06 ,31.99,29.77,29.73,29.65,29.57,29.43,29.34,28.76,25.83,22.76,16.95,14.20.
HRMS(ESI-TOF)m/z:[M-Br]+Calcd for C34H52N3O4 566.3952;Found 566.3959.HRMS (ESI-TOF) m/z: [M-Br]+Calcd for C 34 H 52 N 3 O 4 566.3952; Found 566.3959.
实施例9Example 9
吡啶季铵盐酰肼化合物表面张力的测试:Test of surface tension of pyridinium quaternary ammonium hydrazide compound:
按照实施例1中(1)、(2)和(3)的方法合成了碳链长度为8(结构如式4a所示)、10(结构如式4b所示)、12(结构如式4c所示)、14(结构如式4d所示)、16(结构如式4e所示)的吡啶季铵盐酰肼化合物,这些化合物在水中均具有良好的溶解性。测试表面张力过程中以20mL水为基准,逐渐加入配置好浓度为0.005mol/L的待测样品溶液,最后以加入样品浓度的logC为横坐标,水的表面张力值为纵坐标作图,得到表面张力-浓度曲线示意图。具体的测试结果如图1所示。According to the method of (1), (2) and (3) in Example 1, the carbon chain lengths of 8 (structure as shown in
具体的测试结果如图1所示,图1是吡啶季铵盐酰肼化合物的表面张力-浓度曲线示意图。由图中可以看出,当碳链长度为8-16时,加入待测样品后水的表面张力均有所下降,说明该吡啶季铵盐酰肼化合物均能有效地降低水的表面张力。当碳链长度从8增加到12时,化合物降低水表面张力的作用逐渐增强,但继续增加碳链的长度为14和16时,其表面活性反而减弱。当碳链长度为12时,它能使水的表面张力降低到25.5mN/m左右,说明其是一个十分良好的表面活性剂。以下以它为基体和各种不同香料醛酮进行反应生成相应的腙类化合物,再对其进行抗菌及释放香料的性能进行测试。The specific test results are shown in Figure 1, which is a schematic diagram of the surface tension-concentration curve of the pyridinium quaternary ammonium salt hydrazide compound. As can be seen from the figure, when the carbon chain length is 8-16, the surface tension of water decreases after adding the sample to be tested, indicating that the pyridine quaternary ammonium hydrazide compound can effectively reduce the surface tension of water. When the carbon chain length increased from 8 to 12, the effect of the compound on reducing the surface tension of water gradually increased, but when the carbon chain length continued to increase to 14 and 16, its surface activity weakened instead. When the carbon chain length is 12, it can reduce the surface tension of water to about 25.5mN/m, indicating that it is a very good surfactant. In the following, it is used as a substrate to react with various fragrance aldehydes and ketones to generate corresponding hydrazone compounds, and then its antibacterial and fragrance-releasing properties are tested.
实施例10Example 10
吡啶季铵盐腙类化合物及吡啶季铵盐酰肼化合物的抑菌性能测试:Bacteriostasis test of pyridinium quaternary ammonium hydrazone compounds and pyridinium quaternary ammonium hydrazide compounds:
将实施例1至8制备的8个吡啶季铵盐腙类化合物及实施例9制备的吡啶季铵盐酰肼化合物:碳链长度为8(结构如式4a所示)、碳链长度为10(结构如式4b所示)、碳链长度为12(结构如式4c所示)、碳链长度为14(结构如式4d所示)、碳链长度为16(结构如式4e所示),分别称取上述化合物12.8mg置于容量瓶中,加水稀释至浓度为1280μg/mL,用0.45μm有机相滤头过滤,确保产物水溶液中无细菌存在。随后依次将上述水溶液稀释至浓度为:640,320,160,80,40,20,10,5,2.5,1.25μg/mL。移液枪移取10μL不同浓度的上述溶液至96孔板中,并在每个孔板中添加90μL浓度为105cfu/mL的细菌培养基,添加完毕后,将96孔板在37℃恒温箱中放置24小时,观察细菌生长情况,以获得抑制细菌生长的最低浓度,即为MIC值。MIC值越低,化合物的抑菌性能就越好,具体的数据结果如表1所示。The 8 pyridine quaternary ammonium salt hydrazone compounds prepared in Examples 1 to 8 and the pyridine quaternary ammonium salt hydrazide compound prepared in Example 9: the carbon chain length is 8 (structure shown in
表1Table 1
从表1中可以看出,吡啶季铵盐腙类化合物或者吡啶季铵盐酰肼化合物对革兰氏阳性菌和革兰氏阴性菌具有广谱的抗菌性,在一定浓度下均可杀死抑制细菌细胞的生长。吡啶季铵盐腙类化合物发挥作用的前提是:带有正电极性头基的化合物通过与表面呈负电荷的细菌细胞膜发生静电相互作用,选择性的吸附在细菌表面,细菌细胞质膜的通透性发生改变,细菌中的重要酶及营养物质流出,细菌细胞死亡从而达到杀菌的目的。因此,碳链长度越长抗菌性能就越好,而当碳链长度增加到一定程度时,吸附力下降,直接影响吡啶季铵盐腙类化合物与细菌接触的决定性条件从而影响抗菌效果。从表1的数据可以看出,无论是吡啶季铵盐腙类化合物亦或是吡啶季铵盐酰肼化合物,结构中含有12或14个碳的化合物抑菌效果比含有8、10或16个碳的化合物要更好。同样,由于革兰氏阳性菌只有一层细胞壁与细胞膜没有密切联系,因此,大多数化合物对于革兰氏阳性菌的抑菌效果要强于革兰氏阴性菌。As can be seen from Table 1, pyridinium quaternary ammonium hydrazone compounds or pyridinium quaternary ammonium hydrazide compounds have broad-spectrum antibacterial properties against Gram-positive bacteria and Gram-negative bacteria, and can be killed at a certain concentration. Inhibits the growth of bacterial cells. The prerequisite for pyridine quaternary ammonium hydrazone compounds to function is that the compound with a positively polarized head group undergoes electrostatic interaction with the negatively charged bacterial cell membrane on the surface, selectively adsorbs on the bacterial surface, and penetrates the bacterial cell plasma membrane. Sex changes, important enzymes and nutrients in bacteria flow out, and bacterial cells die to achieve the purpose of sterilization. Therefore, the longer the carbon chain length, the better the antibacterial performance, and when the carbon chain length increases to a certain extent, the adsorption force decreases, which directly affects the decisive conditions for the contact between pyridine quaternary ammonium hydrazone compounds and bacteria, thereby affecting the antibacterial effect. As can be seen from the data in Table 1, whether it is a pyridinium quaternary ammonium hydrazone compound or a pyridinium quaternary ammonium hydrazide compound, the antibacterial effect of the compound containing 12 or 14 carbons in the structure is higher than that containing 8, 10 or 16 carbons. Compounds of carbon are better. Also, since Gram-positive bacteria have only one cell wall that is not closely associated with the cell membrane, most compounds are more potent against Gram-positive bacteria than Gram-negative bacteria.
观察表1中A、B、C、D这四种含有相同长碳链,却与不同芳香醛酮反应所得的吡啶季铵盐腙类化合物的MIC值可以发现,该系列化合物对细菌细胞的抑菌性不止和长碳链有关。这是由于吡啶季铵盐腙类化合物中含有亚胺键(-CONHN=CH-)这一活性官能团,其中含有的氧、氮原子可以参与生物中氢键的形成,抑制许多生化过程的发生,从而具备良好的抗菌活性。Observing the MIC values of the four pyridine quaternary ammonium salt hydrazone compounds containing the same long carbon chain but reacting with different aromatic aldehydes and ketones in Table 1, it can be found that the inhibitory effect of this series of compounds on bacterial cells Bacteria is not only related to long carbon chains. This is due to the active functional group of imine bond (-CONHN=CH-) contained in the pyridine quaternary ammonium hydrazone compound. The oxygen and nitrogen atoms contained in it can participate in the formation of hydrogen bonds in organisms and inhibit the occurrence of many biochemical processes. So it has good antibacterial activity.
实施例11Example 11
吡啶季铵盐腙类化合物水解释放醛酮类香料物质的检测:Detection of pyridine quaternary ammonium hydrazone compounds hydrolyzed to release aldehydes and ketones fragrance substances:
利用固相微萃取-气相色谱法检测吡啶季铵盐腙类化合物在酸性水溶液中的水解,以及等摩尔量纯香料分子在相同实验条件下的挥发,通过对这两组峰面积数据进行对比,说明吡啶季铵盐腙类化合物具有控制和延缓香料物质释放的作用。Using solid-phase microextraction-gas chromatography to detect the hydrolysis of pyridine quaternary ammonium hydrazone compounds in acidic aqueous solution, and the volatilization of equimolar amounts of pure fragrance molecules under the same experimental conditions, by comparing the peak area data of these two groups, It shows that the pyridine quaternary ammonium hydrazone compound has the function of controlling and delaying the release of fragrance substances.
具体的测试方法为:将0.04mmol吡啶季铵盐腙类化合物添加到密封的顶空瓶中,加入0.5mL无水乙醇(利用水和乙醇的互溶性以更好的溶解样品)和0.5mL柠檬酸-柠檬酸钠缓冲液,随后将顶空瓶置于油浴锅中并在60℃下加热。加热10分钟后,将萃取纤维插入到顶空瓶上部空间内进行萃取10分钟。将针头迅速插入GC的后进样口,在高温下吸附在纤维上的香料成分发生解吸,并顺利进入气相进行分析。解吸时间为5分钟,同时启动气相色谱仪进行数据采集。作为参考,需将纯香料分子进行同样处理。The specific test method is: add 0.04mmol of pyridinium quaternary ammonium hydrazone compound into a sealed headspace bottle, add 0.5mL of absolute ethanol (using the miscibility of water and ethanol to better dissolve the sample) and 0.5mL of lemon acid-sodium citrate buffer, then place the headspace vial in an oil bath and heat at 60 °C. After heating for 10 minutes, the extraction fiber was inserted into the upper space of the headspace bottle and extracted for 10 minutes. Quickly insert the needle into the rear sampling port of the GC, and the fragrance components adsorbed on the fiber are desorbed at high temperature, and enter the gas phase smoothly for analysis. The desorption time was 5 minutes, and the gas chromatograph was started for data acquisition at the same time. For reference, pure fragrance molecules are treated in the same way.
固相微萃取操作条件:通过固相微萃取(SPME)测评醛/酮香料的释放性能,该固相微萃取由SPME固定器和带纤维的针组成。该纤维涂有羧基/聚二甲基硅氧烷(CAR/PDMS)吸附涂层,其直径为75μm。在使用之前,将带有萃取纤维的SPME针插入到GC的后进样口中,并于250℃下进行30分钟的预处理,载气(氦气)的流量保持在1.0mL/min。Solid phase microextraction operating conditions: Aldehyde/ketone fragrance release performance was assessed by solid phase microextraction (SPME) consisting of a SPME holder and a needle with fibers. The fibers were coated with a carboxy/polydimethylsiloxane (CAR/PDMS) adsorption coating and had a diameter of 75 μm. Before use, the SPME needle with the extraction fiber was inserted into the rear inlet of the GC, and pretreated at 250 °C for 30 minutes, and the flow rate of the carrier gas (helium) was kept at 1.0 mL/min.
图2~5显示了各类吡啶季铵盐腙类化合物的顶空释放性能,以时间为横坐标,释放出香气物质的峰面积为纵坐标得到时间-峰面积曲线,图2是吡啶季铵盐腙类化合物A和纯香料物质释放芳香物质的时间-峰面积曲线示意图,图3是吡啶季铵盐腙类化合物B和纯香料物质释放芳香物质的时间-峰面积曲线示意图,图4是吡啶季铵盐腙类化合物C和纯香料物质释放芳香物质的时间-峰面积曲线示意图,图5是吡啶季铵盐腙类化合物D和纯香料物质释放芳香物质的时间-峰面积曲线示意图。Figures 2 to 5 show the headspace release properties of various pyridinium quaternary ammonium salt hydrazone compounds, taking time as the abscissa, and releasing the peak area of the aroma substance as the ordinate to obtain a time-peak area curve, and Fig. 2 is a pyridinium quaternary ammonium Salt hydrazone compounds A and pure fragrance substances release the time-peak area curve schematic diagram of aromatic substances. A schematic diagram of the time-peak area curve of the release of aromatic substances by the quaternary ammonium salt hydrazone compound C and pure fragrance substances.
由图中可以看出,所有纯香料物质的释放量均大于吡啶季铵盐腙类化合物的水解释放量。这是由于在酸性水溶液条件下,吡啶季铵盐腙类化合物的亚胺键发生断裂,水解形成酰肼和芳香醛酮。随着反应的进行,水解逐渐趋于动态平衡,在加热条件下挥发到顶空瓶上层空间中的芳香气相组分逐渐变得稳定,而纯香料物质则由于没有化学作用力束缚的原因,呈现出随时间快速、大量释放的趋势。As can be seen from the figure, the release amount of all pure fragrance substances is greater than the hydrolysis release amount of pyridine quaternary ammonium salt hydrazone compounds. This is due to the fact that under the condition of acidic aqueous solution, the imine bond of the pyridine quaternary ammonium hydrazone compound is broken and hydrolyzed to form hydrazide and aromatic aldehyde and ketone. As the reaction progresses, the hydrolysis gradually tends to a dynamic equilibrium, and the aromatic gas phase components that volatilize into the upper space of the headspace bottle under heating conditions gradually become stable, while the pure fragrance substances show a Tendency for rapid, high-volume release over time.
通过对比几张图可以发现,不同的芳香醛酮分子具有不同的释放速率及释放量。其中,以化合物C及其对应的β-紫罗兰酮释放量最大,这是由于β-紫罗兰酮的沸点仅为126℃,低于其他三种芳香醛。此外,具有不同化学结构的四种吡啶季铵盐腙类化合物的释放情况也显著不同。肉桂醛及β-紫罗兰酮的纯样释放量与各自形成的吡啶季铵盐腙类化合物水解释放出的芳香物质量的比值大于新洋茉莉醛及兔耳草醛(A:18倍、C:17倍对比B:8倍、D:6倍),这归因于化合物A、C中共轭结构的存在使得化学结构更加稳定。由此可以得出,吡啶季铵盐腙类化合物具有控制和延缓香气释放的作用,化合物的不同结构以及芳香物质的不同沸点均可导致香气释放行为的不同。By comparing several pictures, it can be found that different aromatic aldehyde and ketone molecules have different release rates and release amounts. Among them, the release amount of compound C and its corresponding β-ionone is the largest, because the boiling point of β-ionone is only 126°C, which is lower than the other three aromatic aldehydes. In addition, the release profiles of four pyridinium quaternary ammonium hydrazone compounds with different chemical structures were also significantly different. The ratio of the release amount of pure samples of cinnamaldehyde and β-ionone to the amount of aromatic substances released by the hydrolysis of the pyridine quaternary ammonium salt hydrazone compounds formed respectively is greater than that of Xinyang jasmonal and rabbit ear oxalin (A: 18 times, C: 17 times compared to B: 8 times,
本申请合成的吡啶季铵盐腙类化合物在水溶液中可水解释放醛酮香料物质,而且水解后留在溶液体系中的吡啶季铵盐酰肼化合物还具有良好的表面活性及抗菌能力。如果将其应用于一些弱酸性的洗涤产品,既可以降低水的表面张力,又可对衣物进行杀菌抑菌,同时还能使洗涤产品中的香气留香更久,因此具有一定的市场应用前景。The pyridinium quaternary ammonium hydrazone compounds synthesized in the present application can hydrolyze and release aldehydes, ketones and fragrance substances in aqueous solution, and the pyridinium quaternary ammonium hydrazide compounds remaining in the solution system after hydrolysis also have good surface activity and antibacterial ability. If it is applied to some weakly acidic washing products, it can not only reduce the surface tension of water, but also sterilize and inhibit the bacteria of clothes, and at the same time make the fragrance in washing products last longer, so it has a certain market application prospect .
以上所述仅是本发明的较佳实施例而已,并非对本发明作任何形式上的限制,虽然本发明已以较佳实施例揭露如上,然而并非用以限定本发明,任何熟悉本专利的技术人员在不脱离本发明技术方案范围内,当可利用上述提示的技术内容作出些许更动或修饰为等同变化的等效实施例,但凡是未脱离本发明技术方案的内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与修饰,均仍属于本发明方案的范围内。The above description is only a preferred embodiment of the present invention, and does not limit the present invention in any form. Although the present invention has been disclosed as above with preferred embodiments, it is not intended to limit the present invention. Anyone familiar with the technology of this patent Without departing from the scope of the technical solution of the present invention, personnel can use the technical content of the above prompts to make some changes or modify them into equivalent embodiments with equivalent changes. In essence, any simple modifications, equivalent changes and modifications made to the above embodiments still fall within the scope of the solutions of the present invention.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911152808.0A CN110818624B (en) | 2019-11-22 | 2019-11-22 | Pyridine quaternary ammonium hydrazone compound, preparation method and application in antibacterial or slow release of spices |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911152808.0A CN110818624B (en) | 2019-11-22 | 2019-11-22 | Pyridine quaternary ammonium hydrazone compound, preparation method and application in antibacterial or slow release of spices |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110818624A CN110818624A (en) | 2020-02-21 |
CN110818624B true CN110818624B (en) | 2022-11-22 |
Family
ID=69558197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911152808.0A Active CN110818624B (en) | 2019-11-22 | 2019-11-22 | Pyridine quaternary ammonium hydrazone compound, preparation method and application in antibacterial or slow release of spices |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110818624B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750088A (en) * | 1993-03-30 | 1998-05-12 | The Dupont Merck Pharmaceutical Company | Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals |
CN1373747A (en) * | 1999-07-09 | 2002-10-09 | 宝洁公司 | Process for making amine componds |
WO2006100647A1 (en) * | 2005-03-24 | 2006-09-28 | Firmenich Sa | Hydrogels for the controlled release of bioactive materials |
CN101001832A (en) * | 2004-08-05 | 2007-07-18 | 弗门尼舍有限公司 | Use of dynamic mixtures for a controlled release of fragrances |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060111270A1 (en) * | 2002-08-02 | 2006-05-25 | Sergey Selifonov | Ketocampholenic acid derivatives and their use in fragrance applications |
DE102016223412A1 (en) * | 2016-11-25 | 2018-05-30 | Henkel Ag & Co. Kgaa | Cyclic ketals as perfume precursors |
-
2019
- 2019-11-22 CN CN201911152808.0A patent/CN110818624B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750088A (en) * | 1993-03-30 | 1998-05-12 | The Dupont Merck Pharmaceutical Company | Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals |
CN1373747A (en) * | 1999-07-09 | 2002-10-09 | 宝洁公司 | Process for making amine componds |
CN101001832A (en) * | 2004-08-05 | 2007-07-18 | 弗门尼舍有限公司 | Use of dynamic mixtures for a controlled release of fragrances |
WO2006100647A1 (en) * | 2005-03-24 | 2006-09-28 | Firmenich Sa | Hydrogels for the controlled release of bioactive materials |
Non-Patent Citations (4)
Title |
---|
Controlled Release of Volatile Aldehydes and Ketones from Dynamic Mixtures Generated by Reversible Hydrazone Formation;Barbara Levrand,et al;《Helvetica Chimica Acta》;20071231;第90卷;第2281-2314页 * |
吡啶季铵盐表面活性剂的杀菌活性研究;李银涛;《长治医学院学报》;20100228;第24卷(第01期);第10-12页 * |
基于纳米尺寸低聚硅倍半氧烷潜香体的合成、表征及其香料醛分子缓释性能研究;韩建伟 等;《中国科学: 化学》;20190118;第49卷(第4期);第597-606页 * |
香草醛缩2,4-二硝基苯腙的合成和抑菌性研究;许同桃等;《化工时刊》;20080303;第22卷(第03期);第44-46页 * |
Also Published As
Publication number | Publication date |
---|---|
CN110818624A (en) | 2020-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tricot et al. | Colloidal catalyst-coated semiconductors in surfactant vesicles: in situ generation of rhodium-coated cadmium sulfide particles in dihexadecyl phosphate vesicles and their utilization for photosensitized charge separation and hydrogen generation | |
JPS5921660B2 (en) | Method for producing catalyst supported on support | |
CN107474047B (en) | Synthesis method of 1,2, 4-triazolo heterocyclic compound | |
Ghosh et al. | A functionalized UiO-66 MOF acting as a luminescent chemosensor for selective and sensitive turn-on detection of superoxide and acetylacetone | |
CN107855134B (en) | Asymmetric imine-pyridine-cobalt metal catalyst and preparation method and application thereof | |
CN110818624B (en) | Pyridine quaternary ammonium hydrazone compound, preparation method and application in antibacterial or slow release of spices | |
JP5700624B2 (en) | Cross coupling catalyst composed of ultrafine transition metal particles and cross coupling method using the same | |
CN101768151A (en) | 2-(2-pyridyl)-8-sulfonamidoquinoline derivative, synthesis method and application thereof | |
CN105115953A (en) | Ratio type nanosphere sensor and preparation method and application thereof | |
CN107880269B (en) | Polyhedral oligomeric sesquisiloxane group-containing compound and use thereof | |
Tovrog et al. | Oxidation of ruthenium coordinated alcohols by molecular oxygen to ketones and hydrogen peroxide | |
CN108126754B (en) | A kind of asymmetric nitrogen hydrogen-pyridine-nickel metal catalyst and its preparation method and application | |
CN108358966A (en) | Novel targeting-mitochondrial function enhancing drug Mito-VB3 and preparation method and application thereof | |
Raja et al. | Spectroscopic, catalytic, and biological studies on mononuclear ruthenium (II) ONSN chelating thiosemicarbazone complexes | |
CN117443380A (en) | Biochar-supported iron catalyst and application thereof | |
CN102050712B (en) | A kind of preparation method of anisaldehyde | |
CN110467527A (en) | A method of preparing trans-D-chrysanthemic acid | |
CN111892627B (en) | Synthetic method of α-aminophosphorus oxide | |
CN103933973A (en) | Preparation method of supported nano palladium/carbon catalyst | |
CN110845357B (en) | Quaternary ammonium salt type hydrazide compound, quaternary ammonium salt type hydrazone compound prepared from same and application of quaternary ammonium salt type hydrazone compound | |
CN104833644A (en) | Schiff base probe used for detecting nickel ions as well as preparation method and application thereof | |
CN115232115B (en) | A dichloroquinoline-oxazoline chiral ligand and its preparation method and application | |
CN104830314A (en) | Furan, thienyl fluorescein type OCl-fluorescence probe and its preparation method and application | |
CN110627723A (en) | A kind of trifluoromethylpyrazole derivative and its application | |
JP3915002B2 (en) | Enantiomerically pure pyridylcycloalkylethylamine and its salts and their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |